chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Feeling hot, Headache, Lymphadenopathy
Clinical narrative: Arm was swollen; left arm was tingling; swollen lymph nodes in her neck; arm was warm; body aches; chills; fatigue; headache; This spontaneous case was reported by a nurse and describes the occurrence of PERIPHERAL SWELLING (Arm was swollen), PARAESTHESIA (left arm was tingling), LYMPHADENOPATHY (swollen lymph nodes in her neck), FEELING HOT (arm was warm) and MYALGIA (body aches) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 27-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-May-2021, the patient experienced PERIPHERAL SWELLING (Arm was swollen), PARAESTHESIA (left arm was tingling), FEELING HOT (arm was warm), MYALGIA (body aches), CHILLS (chills), FATIGUE (fatigue) and HEADACHE (headache). 26-May-2021, the patient experienced LYMPHADENOPATHY (swollen lymph nodes in her neck). On 31-May-2021, PERIPHERAL SWELLING (Arm was swollen), FEELING HOT (arm was warm), MYALGIA (body aches), CHILLS (chills), FATIGUE (fatigue) and HEADACHE (headache) had resolved. At the time of the report, PARAESTHESIA (left arm was tingling) and LYMPHADENOPATHY (swollen lymph nodes in her neck) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided.  Concomitant information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 30-Jun-2021: no new information.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Paraesthesia, Peripheral swelling
Clinical narrative: Arm was swollen; left arm was tingling; swollen lymph nodes in her neck; arm was warm; body aches; chills; fatigue; headache; This spontaneous case was reported by a nurse and describes the occurrence of PERIPHERAL SWELLING (Arm was swollen), PARAESTHESIA (left arm was tingling), LYMPHADENOPATHY (swollen lymph nodes in her neck), FEELING HOT (arm was warm) and MYALGIA (body aches) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 27-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-May-2021, the patient experienced PERIPHERAL SWELLING (Arm was swollen), PARAESTHESIA (left arm was tingling), FEELING HOT (arm was warm), MYALGIA (body aches), CHILLS (chills), FATIGUE (fatigue) and HEADACHE (headache). 26-May-2021, the patient experienced LYMPHADENOPATHY (swollen lymph nodes in her neck). On 31-May-2021, PERIPHERAL SWELLING (Arm was swollen), FEELING HOT (arm was warm), MYALGIA (body aches), CHILLS (chills), FATIGUE (fatigue) and HEADACHE (headache) had resolved. At the time of the report, PARAESTHESIA (left arm was tingling) and LYMPHADENOPATHY (swollen lymph nodes in her neck) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided.  Concomitant information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 30-Jun-2021: no new information.
Sex: M
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: Fatigue; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FATIGUE (Fatigue). At the time of the report, FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported. Treatment medication was not provided.   This case was linked to MOD-2021-193834 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: I got the first dose Feb 9th, I have not had the 2nd dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (I got the first dose Feb 9th, I have not had the 2nd dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (I got the first dose Feb 9th, I have not had the 2nd dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (I got the first dose Feb 9th, I have not had the 2nd dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment medications were reported.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Product administered to patient of inappropriate age
Clinical narrative: arm was sore; 17 years old at the time of vaccination; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 years old at the time of vaccination) and PAIN IN EXTREMITY (arm was sore) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Jan-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 years old at the time of vaccination). On an unknown date, the patient experienced PAIN IN EXTREMITY (arm was sore). On 13-Jan-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 years old at the time of vaccination) had resolved. At the time of the report, PAIN IN EXTREMITY (arm was sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 01-Jun-2021: Follow-up information received on 01-JUN-2021. No new information was updated.
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Product administered to patient of inappropriate age
Clinical narrative: Sore left arm; Inappropriate age at vaccine administration; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore left arm) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Inappropriate age at vaccine administration) in a 16-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO) and AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL) for an unknown indication.    On 03-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore left arm) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Inappropriate age at vaccine administration). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Symptomatic treatment, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Sore left arm) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Inappropriate age at vaccine administration) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to MOD-2021-193597 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Peripheral swelling
Clinical narrative: Swollen arm; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swollen arm) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (Swollen arm). At the time of the report, PERIPHERAL SWELLING (Swollen arm) outcome was unknown.            No concomitant medications were reported. No treatment medications were reported.  Action taken with mRNA-1273 in response to the event was not applicable.
Sex: U
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: itch in the arm i got the vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itch in the arm i got the vaccine) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRURITUS (itch in the arm i got the vaccine). At the time of the report, PRURITUS (itch in the arm i got the vaccine) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product information was not provided.  Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: My are turned red around and under the area where I got my shot; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (My are turned red around and under the area where I got my shot) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 29-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-May-2021, the patient experienced VACCINATION SITE ERYTHEMA (My are turned red around and under the area where I got my shot). At the time of the report, VACCINATION SITE ERYTHEMA (My are turned red around and under the area where I got my shot) had not resolved.            Concomitant product information was not provided.  Treatment included an unspecified cream.
Sex: U
Vaccine: COVID19
Symptoms: Weight decreased
Clinical narrative: lost a lot of weight /weight loss; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of WEIGHT DECREASED (lost a lot of weight /weight loss) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced WEIGHT DECREASED (lost a lot of weight /weight loss). At the time of the report, WEIGHT DECREASED (lost a lot of weight /weight loss) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Patient missed her 2nd dose, more than 42 days; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient missed her 2nd dose, more than 42 days) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient missed her 2nd dose, more than 42 days). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient missed her 2nd dose, more than 42 days) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Eye swelling, Ocular discomfort, Vision blurred
Clinical narrative: Swelling in eyes; blurry vision periodically/ could not focus; Tight felling in eyes; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of EYE SWELLING (Swelling in eyes), VISION BLURRED (blurry vision periodically/ could not focus) and OCULAR DISCOMFORT (Tight felling in eyes) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017C21A and 026B21A) for COVID-19 vaccination.     Concurrent medical conditions included Sulfonamide allergy (sulpha allergy), Gluten intolerance (gluten allergy), Prediabetes since 09-Jan-2016 and Chiari malformation since 05-Dec-2019. Concomitant products included MIDODRINE for Redness and Irritation eye, DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) from 01-Jan-1999 to an unknown date, LORATADINE (CLARITINO) from 01-Jan-1999 to an unknown date, MULTIVITAMIN [VITAMINS NOS] from 01-Jan-2021 to an unknown date and PARACETAMOL (TYLENOL) from 20-Apr-2021 to an unknown date for an unknown indication.   On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Apr-2021, the patient experienced VISION BLURRED (blurry vision periodically/ could not focus) and OCULAR DISCOMFORT (Tight felling in eyes). On 26-Apr-2021 at 2:00 PM, the patient experienced EYE SWELLING (Swelling in eyes). At the time of the report, EYE SWELLING (Swelling in eyes) had not resolved and VISION BLURRED (blurry vision periodically/ could not focus) and OCULAR DISCOMFORT (Tight felling in eyes) outcome was unknown.            No treatment information was provided by the reporter.  After, 10 minutes into waiting the patient started getting blurry vision. The patient had this happen before when her blood sugar raises over 150 but she had not eaten anything. The patient managed to drive to mothers a few blocks away and sat there with her until it subsided more. It kept happening when the patient was reading.   The patient went for an eye appointment where the optometrist checked her eyes and took eye pictures. The optometrist did a diabetic eye check and dilated my eyes.   Most recent FOLLOW-UP information incorporated above includes: On 04-Aug-2021: Follow up received on 04-Aug-2021 : Updated reporter information(salutation) and patient demographics, added relevant medical history information, concomitant medications details(multivitamin, tylenol) and facility details were updated; Updated route of administration of Dose 2 (intramuscular to unknown); Additional new event(eye swelling) was added.
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Product administered to patient of inappropriate age, Pyrexia
Clinical narrative: Inappropriate age at vaccine administration; Fever of 102.3 F; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever of 102.3 F) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Inappropriate age at vaccine administration) in a 16-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO) and AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL) for an unknown indication.   On 03-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 31-May-2021, the patient experienced PYREXIA (Fever of 102.3 F). On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Inappropriate age at vaccine administration). At the time of the report, PYREXIA (Fever of 102.3 F) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Inappropriate age at vaccine administration) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 31-May-2021, Body temperature: 102.3 (High) 102.3 F.         No treatment information was provided.   This case was linked to MOD-2021-193560 (Patient Link).
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cough, Myalgia, Pyrexia, SARS-CoV-2 test
Clinical narrative: Body aches; Low grade fever; Chills; Cough; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of COUGH (Cough), MYALGIA (Body aches), PYREXIA (Low grade fever) and CHILLS (Chills) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022C21A) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy, Drug allergy (morphine), Sulfonamide allergy (sulfa) and Drug allergy (hydrocodone).   On 11-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced COUGH (Cough). On 12-May-2021, the patient experienced MYALGIA (Body aches), PYREXIA (Low grade fever) and CHILLS (Chills). The patient was treated with CODEINE for Cough, at a dose of 1 dosage form and ALBUTEROL [SALBUTAMOL] for Cough, at a dose of 1 dosage form. On 13-May-2021, MYALGIA (Body aches), PYREXIA (Low grade fever) and CHILLS (Chills) had resolved. At the time of the report, COUGH (Cough) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: negative (Negative) tested for Covid-19, test negative.         Concomitant product information was not provided.  On unknown date, consumer was seen by a nurse practitioner who prescribed cough syrup with codeine, and albuterol.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Inappropriate schedule of product administration, Pyrexia
Clinical narrative: fever; was tired/fatigue; second dose was 14 days after the first dose; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose was 14 days after the first dose), PYREXIA (fever) and FATIGUE (was tired/fatigue) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 15-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-May-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose was 14 days after the first dose). On 31-May-2021, the patient experienced PYREXIA (fever) and FATIGUE (was tired/fatigue). The patient was treated with PARACETAMOL (TYLENOL) on 31-May-2021 for Fever and Tiredness, at an unspecified dose and frequency. On 30-May-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose was 14 days after the first dose) had resolved. At the time of the report, PYREXIA (fever) and FATIGUE (was tired/fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were mentioned. Safety follow up consent was obtained.
Sex: U
Vaccine: COVID19
Symptoms: Ear pain, Headache
Clinical narrative: pain in your ears; long term headaches; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a non-health professional and describes the occurrence of EAR PAIN (pain in your ears) and HEADACHE (long term headaches) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EAR PAIN (pain in your ears) and HEADACHE (long term headaches). At the time of the report, EAR PAIN (pain in your ears) and HEADACHE (long term headaches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant drugs are not given. Treatment information not provided.   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Invalid dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of INCORRECT DOSE ADMINISTERED (Invalid dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INCORRECT DOSE ADMINISTERED (Invalid dose). At the time of the report, INCORRECT DOSE ADMINISTERED (Invalid dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: Shaking uncontrollably/shaking violently like seizure attack; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (Shaking uncontrollably/shaking violently like seizure attack) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ROSUVASTATIN CALCIUM (CRESTOR), DIGOXIN, DILTIAZEM, FOLIC ACID, METHOTREXATE, POTASSIUM CHLORIDE (KLOR CON), PROPYLTHIOURACIL, HYDROCHLOROTHIAZIDE, TRIAMTERENE (TRIAMTERENE/HCTZ) and APIXABAN (ELIQUIS) for an unknown indication.   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Jan-2021, the patient experienced TREMOR (Shaking uncontrollably/shaking violently like seizure attack). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) on 12-Jan-2021 for Symptomatic treatment, at a dose of 1 dosage form. In January 2021, TREMOR (Shaking uncontrollably/shaking violently like seizure attack) had resolved.            The patient's symptoms began at 10:00 PM. The patient called 911, and by the time the paramedics arrived, the shakiness started to settle down. The paramedics recommended that the patient take Benadryl to treat her symptoms and left within 30 minutes.   This case was linked to MOD-2021-193735 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Adverse event, Illness
Clinical narrative: significant side effects/things are coming up that I didn't have issues with in a long time; very sick; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (significant side effects/things are coming up that I didn't have issues with in a long time) and ILLNESS (very sick) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In April 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In April 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (significant side effects/things are coming up that I didn't have issues with in a long time) and ILLNESS (very sick). At the time of the report, ADVERSE EVENT (significant side effects/things are coming up that I didn't have issues with in a long time) and ILLNESS (very sick) outcome was unknown.            No concomitant medications were reported.  Treatment medications were not provided by the reporter.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Exposure to SARS-CoV-2, Nausea, Rash
Clinical narrative: got exposed to COVID; dizziness; big rash; nausea; This spontaneous case was reported by a patient and describes the occurrence of EXPOSURE TO SARS-COV-2 (got exposed to COVID), DIZZINESS (dizziness), RASH (big rash) and NAUSEA (nausea) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 03-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced EXPOSURE TO SARS-COV-2 (got exposed to COVID), DIZZINESS (dizziness), RASH (big rash) and NAUSEA (nausea). At the time of the report, EXPOSURE TO SARS-COV-2 (got exposed to COVID), DIZZINESS (dizziness), RASH (big rash) and NAUSEA (nausea) outcome was unknown.            Patient got exposed to COVID before receiving second dose. No relevant concomitant medication was reported. Treatment information was not provided.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: 8 doses given today after vial was punctured 30May2021. Technician did not know vial was from 30May2021".; This spontaneous case was reported by an other health care professional and describes the occurrence of INCORRECT DOSE ADMINISTERED (8 doses given today after vial was punctured 30May2021. Technician did not know vial was from 30May2021".) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Jun-2021, the patient experienced INCORRECT DOSE ADMINISTERED (8 doses given today after vial was punctured 30May2021. Technician did not know vial was from 30May2021".). At the time of the report, INCORRECT DOSE ADMINISTERED (8 doses given today after vial was punctured 30May2021. Technician did not know vial was from 30May2021".) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications reported.  No treatment information was provided.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Mobility decreased, Pruritus, Urticaria
Clinical narrative: at night, hives started on thigh, neck and all over the abdomen; headache, progressively got worse for 3 days; Itching; could not sit up because of the pressure; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (at night, hives started on thigh, neck and all over the abdomen), PRURITUS (Itching), MOBILITY DECREASED (could not sit up because of the pressure) and HEADACHE (headache, progressively got worse for 3 days) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036B21A) for COVID-19 vaccination.     The patient's past medical history included Anaphylaxis and Asthma. Concurrent medical conditions included Hypersensitivity, Hay fever and Hives. Concomitant products included PROGESTERONE, VITAMIN B [VITAMIN B NOS], VITAMIN D NOS, DHEA, MAGNESIUM and FISH OIL for an unknown indication.   On 26-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Apr-2021, the patient experienced PRURITUS (Itching) and MOBILITY DECREASED (could not sit up because of the pressure). On 26-May-2021, the patient experienced URTICARIA (at night, hives started on thigh, neck and all over the abdomen) and HEADACHE (headache, progressively got worse for 3 days). The patient was treated with PARACETAMOL (TYLENOL) for Headache, at a dose of 1 dosage form and LORATADINE (CLARITIN [LORATADINE]) from 28-May-2021 to 30-May-2021 for Hives, at a dose of 1 dosage form. On 24-May-2021, PRURITUS (Itching) had resolved. On 26-May-2021, MOBILITY DECREASED (could not sit up because of the pressure) outcome was unknown. On 29-May-2021, HEADACHE (headache, progressively got worse for 3 days) had resolved. At the time of the report, URTICARIA (at night, hives started on thigh, neck and all over the abdomen) outcome was unknown.            Treatment medication were not reported. The action taken with mRNA-1273 (Moderna CoviD-19 Vaccine) (Not applicable) was Not applicable.   This case was linked to MOD-2021-268117, MOD-2021-268117 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 27-Jul-2021: Significant follow up received on 27Jul2021 contains itching as an event , relevant history and concomitant drugs.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Eye swelling
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of EYE SWELLING (both eyes are swollen) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041C21A and 001C21A) for COVID-19 vaccination. No Medical History information was reported. On 26-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 25-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Jun-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EYE SWELLING (both eyes are swollen). At the time of the report, EYE SWELLING (both eyes are swollen) outcome was unknown. No relevant concomitant medications were reported. No treatment information was provided. This case was linked to MOD-2021-193450.
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: Shaking uncontollably/violently like seizure attack; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (Shaking uncontollably/violently like seizure attack) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030M20A and 012L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ROSUVASTATIN CALCIUM (CRESTOR), DIGOXIN, DILTIAZEM, FOLIC ACID, METHOTREXATE, POTASSIUM CHLORIDE (KLOR CON), PROPYLTHIOURACIL, HYDROCHLOROTHIAZIDE, TRIAMTERENE (TRIAMTERENE & HCTZ) and APIXABAN (ELIQUIS) for an unknown indication.   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced TREMOR (Shaking uncontollably/violently like seizure attack). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Tremor, at an unspecified dose and frequency. At the time of the report, TREMOR (Shaking uncontollably/violently like seizure attack) had resolved.            The reporter was calling on behalf of one of their family members who developed adverse events after receiving both the doses of Moderna vaccine. The patient received the 2nd dose of Moderna vaccine on 09-Feb-2021 and by 7:00 pm, on the same day of vaccination, the patient started the symptom of shaking uncontrollably and violently like seizure attack. The symptom went away with in an hour and took 2 to 3 days for the patient to recover from the symptom completely. The patient took Benadryl medications as advised by the para meds for the symptoms developed.   This case was linked to MOD-2021-193645 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2021: Follow-up was received on 08-Jun-2021 and Updated the lot number of the second dose.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Received the 1st dose > 35 Days and is determined not to get the 2nd one.; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Received the 1st dose > 35 Days and is determined not to get the 2nd one.) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032MZ0A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Received the 1st dose > 35 Days and is determined not to get the 2nd one.). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Received the 1st dose > 35 Days and is determined not to get the 2nd one.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Treatment medications were provided No  Concomitant medications were provided
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: "Is that any side effects?" - Experiencing side effects? "Yes, it's correct"; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION COMPLICATION ("Is that any side effects?" - Experiencing side effects? "Yes, it's correct") in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION ("Is that any side effects?" - Experiencing side effects? "Yes, it's correct"). At the time of the report, VACCINATION COMPLICATION ("Is that any side effects?" - Experiencing side effects? "Yes, it's correct") outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of pruritus (itchy) in a female patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On May 19, 2021, patient received a dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; unknown. On May 19, 2021, patient experienced pruritus (itchy). The patient treated with rubbing alcohol (isopropanol) for itching, at an unspecified dose and frequency. At the time of the report, pruritus (itchy): resolving. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. Concomitant product use not provided.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Fear, Product dose omission issue
Clinical narrative: Terrified; It has been more than 42 days since his received his first dose.; This spontaneous case was reported by a consumer and describes the occurrence of FEAR (Terrified) and PRODUCT DOSE OMISSION ISSUE (It has been more than 42 days since his received his first dose.) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No medical history was reported by the reporter.  Concomitant products included APIXABAN (ELIQUIS) and METFORMIN for an unknown indication.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced FEAR (Terrified) and PRODUCT DOSE OMISSION ISSUE (It has been more than 42 days since his received his first dose.). At the time of the report, FEAR (Terrified) and PRODUCT DOSE OMISSION ISSUE (It has been more than 42 days since his received his first dose.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 03-Jun-2021: Contact information and Date of birth updated
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Inappropriate age at vaccine administration; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Jun-2021 and was forwarded to Moderna on 01-Jun-2021.    This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Inappropriate age at vaccine administration) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025C21A and 008C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 30-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-May-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Inappropriate age at vaccine administration). On 28-May-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Inappropriate age at vaccine administration) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19 screening, Hypersensitivity, Lower respiratory tract infection, Myalgia, Nasal congestion
Clinical narrative: Feels like a regular chest cold; Having allergies; Sore throat; Stuffy nose; Cold; Body is sore; This spontaneous case was reported by a consumer and describes the occurrence of LOWER RESPIRATORY TRACT INFECTION (Feels like a regular chest cold), HYPERSENSITIVITY (Having allergies), OROPHARYNGEAL PAIN (Sore throat), NASAL CONGESTION (Stuffy nose) and NASOPHARYNGITIS (Cold) in a 19-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 05-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced LOWER RESPIRATORY TRACT INFECTION (Feels like a regular chest cold), HYPERSENSITIVITY (Having allergies), OROPHARYNGEAL PAIN (Sore throat), NASAL CONGESTION (Stuffy nose), NASOPHARYNGITIS (Cold) and MYALGIA (Body is sore). At the time of the report, LOWER RESPIRATORY TRACT INFECTION (Feels like a regular chest cold), HYPERSENSITIVITY (Having allergies), OROPHARYNGEAL PAIN (Sore throat), NASAL CONGESTION (Stuffy nose), NASOPHARYNGITIS (Cold) and MYALGIA (Body is sore) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Jun-2021, COVID-19 screening: inconclusive (Inconclusive) She does not have the result.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant and treatment information was not reported.  Company comment: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Nasopharyngitis, Oropharyngeal pain
Clinical narrative: Feels like a regular chest cold; Having allergies; Sore throat; Stuffy nose; Cold; Body is sore; This spontaneous case was reported by a consumer and describes the occurrence of LOWER RESPIRATORY TRACT INFECTION (Feels like a regular chest cold), HYPERSENSITIVITY (Having allergies), OROPHARYNGEAL PAIN (Sore throat), NASAL CONGESTION (Stuffy nose) and NASOPHARYNGITIS (Cold) in a 19-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 05-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced LOWER RESPIRATORY TRACT INFECTION (Feels like a regular chest cold), HYPERSENSITIVITY (Having allergies), OROPHARYNGEAL PAIN (Sore throat), NASAL CONGESTION (Stuffy nose), NASOPHARYNGITIS (Cold) and MYALGIA (Body is sore). At the time of the report, LOWER RESPIRATORY TRACT INFECTION (Feels like a regular chest cold), HYPERSENSITIVITY (Having allergies), OROPHARYNGEAL PAIN (Sore throat), NASAL CONGESTION (Stuffy nose), NASOPHARYNGITIS (Cold) and MYALGIA (Body is sore) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Jun-2021, COVID-19 screening: inconclusive (Inconclusive) She does not have the result.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant and treatment information was not reported.  Company comment: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Amnesia, Blood pressure increased, Blood pressure measurement, Chills, Computerised tomogram
Clinical narrative: Felt funny; Fever; Chills; Diarrhea; Problem with speech; Problem with short term memory; Couldn't remember anything; Problem with leg and feet swelling; Blood pressure was sky high; Did not receive second dose; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Felt funny), PYREXIA (Fever), CHILLS (Chills), DIARRHOEA (Diarrhea) and SPEECH DISORDER (Problem with speech) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Shellfish allergy. Concomitant products included FISH OIL for Memory impaired, CALCIUM, B-Complex and DIURETICS for an unknown indication.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (Felt funny), PYREXIA (Fever), CHILLS (Chills), DIARRHOEA (Diarrhea), SPEECH DISORDER (Problem with speech), AMNESIA (Problem with short term memory), MEMORY IMPAIRMENT (Couldn't remember anything), PERIPHERAL SWELLING (Problem with leg and feet swelling), BLOOD PRESSURE INCREASED (Blood pressure was sky high) and PRODUCT DOSE OMISSION ISSUE (Did not receive second dose). At the time of the report, FEELING ABNORMAL (Felt funny), PYREXIA (Fever), CHILLS (Chills), DIARRHOEA (Diarrhea), SPEECH DISORDER (Problem with speech), AMNESIA (Problem with short term memory), MEMORY IMPAIRMENT (Couldn't remember anything), PERIPHERAL SWELLING (Problem with leg and feet swelling), BLOOD PRESSURE INCREASED (Blood pressure was sky high) and PRODUCT DOSE OMISSION ISSUE (Did not receive second dose) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: (High) Blood pressure was sky high.. On an unknown date, Computerised tomogram: (Negative) For stroke. On an unknown date, Magnetic resonance imaging: (Negative) For stroke.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Other concomitants are Blood pressure medication; cholesterol medication; gout medication; thyroid medications were reported. No concomitant medications were reported.